GSPT1 Functions as a Tumor Promoter in Human Liver Cancer

Yi-qing Xi , Jing-bo Gao , Xuan-fei Li , Li-hua Xu , Zhi Li , Li-jie Yang , Jing Wang , Hua-qiao Wang , Xiao-chang Fang , Si-rui Huang , Wei Xie , Mao-hui Feng , Jing-wei Zhang

Current Medical Science ›› 2022, Vol. 43 ›› Issue (1) : 104 -114.

PDF
Current Medical Science ›› 2022, Vol. 43 ›› Issue (1) : 104 -114. DOI: 10.1007/s11596-022-2665-6
Article

GSPT1 Functions as a Tumor Promoter in Human Liver Cancer

Author information +
History +
PDF

Abstract

Objective

This study analyzed the role of G1 to S phase transition 1 protein (GSPT1) in promoting progression of liver cancer cells.

Methods

A bioinformatics database was used to analyze the expression levels of GSPT1 in liver cancer tissues and the prognosis of patients. Subsequently, Western blotting and quantitative PCR were used to verify the expression levels of GSPT1 between normal hepatocytes and hepatoma cells. We used a CRISPR/Cas9 system to construct knockouts of GSPT1 in HepG2 and HCCLM9 liver cancer cells. The effect of GSPT1 on liver cancer cell migration and invasion was analyzed using flow cytometry, migration, and tumor formation assays.

Results

The Cancer Genome Atlas Liver Hepatocellular Carcinoma dataset indicated that GSPT1 expression was upregulated in liver cancer cell lines, and patients with liver cancer had poor prognosis. Knockout of GSPT1 in cells significantly inhibited tumor proliferation, cell migration, and growth in vivo.

Conclusion

In this study, we found that GSPT1 promotes the migration and invasion of liver cancer cells.

Keywords

G1 to S phase transition 1 protein / liver cancer / migration / invasion

Cite this article

Download citation ▾
Yi-qing Xi, Jing-bo Gao, Xuan-fei Li, Li-hua Xu, Zhi Li, Li-jie Yang, Jing Wang, Hua-qiao Wang, Xiao-chang Fang, Si-rui Huang, Wei Xie, Mao-hui Feng, Jing-wei Zhang. GSPT1 Functions as a Tumor Promoter in Human Liver Cancer. Current Medical Science, 2022, 43(1): 104-114 DOI:10.1007/s11596-022-2665-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

FuJ, WangH. Precision diagnosis and treatment of liver cancer in China. Cancer Lett, 2018, 412: 283-288

[2]

ShiJF, CaoM, WangY, et al.. Is it possible to halve the incidence of liver cancer in China by 2050?. Int J Cancer, 2021, 148(5): 1051-1065

[3]

AnwanwanD, SinghSK, SinghS, et al.. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314

[4]

LimKC, ChowPK, AllenJC, et al.. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg, 2012, 99(12): 1622-1629

[5]

Malta-VacasJ. Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J Clin Pathol, 2005, 58(6): 621-625

[6]

ChauvinC, Jean-JeanO. Proteasomal degradation of human release factor eRF3a regulates translation termination complex formation. RNA, 2007, 14(2): 240-245

[7]

IvanovA, MikhailovaT, EliseevB, et al.. PABP enhances release factor recruitment and stop codon recognition during translation termination. Nucleic Acids Res, 2016, 44(16): 7766-7776

[8]

SunW, ZhangL, YanR, et al.. LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis. Onco Targets Ther, 2019, 12: 3945-3954

[9]

LeeJA, ParkJE, LeeDH, et al.. G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1. Oncogene, 2008, 27(9): 1297-1305

[10]

XiaoR, LiC, ChaiB. miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1. Biomed Pharmacother, 2015, 74: 138-144

[11]

TianQ, TianR, LiuY, et al.. The role of miR-144/GSPT1 axis in gastric cancer. Eur Rev Med Pharmacol Sci, 2018, 22(13): 4138-4145

[12]

Malta-VacasJ, ChauvinC, GonçalvesL, et al.. eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development. Onco Rep, 2009, 21(6): 1551-1558

[13]

ChengZ, GuoJ, ChenL, et al.. Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells. Mol Carcinog, 2016, 55(6): 1048-1059

[14]

KrausS, BenardO, NaorZ, et al.. C-Src Is Activated by the EGF Receptor in a Pathway that Mediates JNK and ERK Activation by Gonadotropin-Releasing Hormone in COS7 Cells. Int J Mol Sci, 2020, 21(22): 8575

[15]

YangZ, SunY, NiZ, et al.. Merging PROTAC and molecular glue for degrading BTK and GSPT1 proteins concurrently. Cell Res, 2021, 31(12): 1315-1318

[16]

ZhangC, ZouY, DaiDQ. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1. Biomed Pharmacother, 2019, 119: 109417

[17]

SteersWD, MalloryB, de GroatWC. Electrophysiological study of neural activity in penile nerve of the rat. Am J Physiol, 1988, 254(6): R989-R1000Pt 2

[18]

LiZ, XieX, FanX, et al.. Long Non-coding RNA MINCR Regulates miR-876-5p/GSPT1 Axis to Aggravate Glioma Progression. Neurochem Res, 2020, 45(7): 1690-1699

[19]

WangS, Beeghly-FadielA, CaiQ, et al.. Gene expression in triple-negative breast cancer in relation to survival. Breast Cancer Res Treat, 2018, 171(1): 199-207

[20]

LongX, ZhaoL, LiG, et al.. Identification of GSPT1 as prognostic biomarker and promoter of malignant colon cancer cell phenotypes via the GSK-3beta/CyclinD1 pathway. Aging (Albany NY), 2021, 13(7): 10354-10368

[21]

LitchfieldK, HolroydA, LloydA, et al.. Identification of four new susceptibility loci for testicular germ cell tumour. Nat Commun, 2015, 6: 8690

[22]

MiriM, HematiS, SafariF, et al.. GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility. Med Oncol, 2012, 29(3): 1581-1585

[23]

NairS, Bora-SinghalN, PerumalD, et al.. Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner. Mol Cancer, 2014, 13(1): 173

AI Summary AI Mindmap
PDF

126

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/